Skin Cancer Risk in Scleroderma Transplant Recipients Under Scrutiny
A JAAD analysis published October 13, 2026 examines how study design shapes reported skin cancer risk in systemic sclerosis patients who undergo organ transplantation.
Topic
Immunosuppression
Topic
Immunosuppression
JAAD Publishes Reply on Skin Cancer Risk in Scleroderma Transplant Patients
Kanwar and Nambudiri reply in JAAD, online October 12, 2026, to Xie et al. on methodological questions in skin cancer risk among…
Immune Cell Dysfunction, Not Absence, Marks Skin Cancer Risk
Nonmelanoma skin cancer in immunosuppressed patients reflects immune cell dysfunction, not absence — a shift that could reshape s…
Dysfunction, Not Absence, of Immune Cells Defines Skin Cancer Risk
MD Anderson researchers report that skin cancers in immunosuppressed patients arise from immune cell dysfunction rather than immu…
Discovery May Open New Treatment Paths for Skin Cancer in Immunosuppressed Patients
A newly reported discovery may enable new skin cancer treatments for immunosuppressed patients, a group in whom immunotherapy rem…